Solara Active Pharma Sciences Limited (BOM:890202)
India
· Delayed Price · Currency is INR 273.00
+12.75 (4.90%)
At close: Apr 3, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2017 - 2018 |
| Active Pharma Ingredient | 12.26B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Active Pharma Ingredient Growth | -10.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services | 119.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services Growth | 130.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 505.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -21.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2017 - 2018 |
| Asia Pacific | 7.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific Growth | -14.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 2.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | -10.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | 1.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | 36.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | 871.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 20.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global | 505.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global Growth | -21.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South America | 58.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South America Growth | -84.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|